Rosiglitazone treatment alleviates inflammation and improves liver function in overweight women with polycystic ovary syndrome: a randomized placebo-controlled study

In a randomized, placebo-controlled study, we studied the effects of 4 months' treatment with rosiglitazone on low-grade inflammation, liver function, lipid levels, and blood pressure in 30 overweight women with polycystic ovary syndrome. Rosiglitazone significantly decreased serum C-reactive p...

Full description

Bibliographic Details

Published in:	Fertility and sterility Vol. 87; no. 1; p. 202
Main Authors:	Rautio, Katrina, Tapanainen, Juha S, Ruokonen, Aimo, Morin-Papunen, Laure C
Format:	Journal Article
Language:	English
Published:	United States 01.01.2007
Subjects:	Adolescent Adult Female Humans Hypoglycemic Agents - administration & dosage Inflammation - drug therapy Liver Diseases - drug therapy Obesity - drug therapy Polycystic Ovary Syndrome - drug therapy Thiazolidinediones - therapeutic use Treatment Outcome
ISSN:	1556-5653, 1556-5653
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!